Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024)

NCT05250908 is registered in ClinicalTrials.gov with Coloplast A/S as lead sponsor.

NCT NCT05250908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024)
Lead sponsor
Coloplast A/S
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 7, 2022
Completion date
June 27, 2026
Enrollment
208 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract symptoms, urinary bladder diseases, urinary bladder, overactive, urinary incontinence, urge, urologic diseases, urological manifestations